kt 6149 has been researched along with Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, H; Ashizawa, T; Gomi, K; Kasai, M; Kobayashi, S; Okabe, M; Okamoto, A; Saito, H | 1 |
1 other study(ies) available for kt 6149 and Breast Cancer
Article | Year |
---|---|
Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice.
Topics: Animals; Antineoplastic Agents; Biotransformation; Breast Neoplasms; Cell Survival; HeLa Cells; Humans; Lethal Dose 50; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Mitomycin; Mitomycins; Rats; Sarcoma 180; Tumor Cells, Cultured | 1995 |